TP53 and skin basal cell carcinoma: The combined injection of SmoA1 and p53-shRNA virus group showed a BCC-like phenotype of 70% after 2 weeks, and the tumor formation rate reached 100% after 4 weeks. Ptch1 and Gli1 mRNA expressions were up-regulated.